Reid M Huber is Director of BELLICUM PHARMACEUTICALS, INC. Currently has a direct ownership of 153,179 shares of BLCM, which is worth approximately $0. The most recent transaction as insider was on Jan 03, 2023, when has been sold 87,196 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 153K
0% 3M change
0% 12M change
Total Value Held $0

Reid M Huber Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 03 2023
BUY
Exercise of conversion of derivative security
-
87,196 Added 36.27%
153,179 Common Stock
Sep 01 2022
BUY
Exercise of conversion of derivative security
-
46,489 Added 41.33%
65,983 Common Stock
Jan 04 2022
BUY
Exercise of conversion of derivative security
-
19,494 Added 50.0%
19,494 Common Stock

Also insider at

TNGX
Tango Therapeutics, Inc. Healthcare
CRGX
CARGO Therapeutics, Inc.
RMH

Reid M Huber

Director
Houston, TX

Track Institutional and Insider Activities on BLCM

Follow BELLICUM PHARMACEUTICALS, INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BLCM shares.

Notify only if

Insider Trading

Get notified when an Bellicum Pharmaceuticals, Inc insider buys or sells BLCM shares.

Notify only if

News

Receive news related to BELLICUM PHARMACEUTICALS, INC

Track Activities on BLCM